Karthik Meduri , Geeta Sandeep Nadella , Akhila Reddy Yadulla , Vinay Kumar Kasula , Mohan Harish Maturi , Steven Brown , Snehal Satish , Hari Gonaygunta
{"title":"Leveraging federated learning for privacy-preserving analysis of multi-institutional electronic health records in rare disease research","authors":"Karthik Meduri , Geeta Sandeep Nadella , Akhila Reddy Yadulla , Vinay Kumar Kasula , Mohan Harish Maturi , Steven Brown , Snehal Satish , Hari Gonaygunta","doi":"10.1016/j.ject.2024.11.001","DOIUrl":null,"url":null,"abstract":"<div><div>This research announces that the fresh federated learning structure is designed to enhance the privacy-preserving analysis of electronic health records (EHRs), and multiple institutions in this framework permit secure collaboration among institutions, allowing them to train machine-learning replicas without directly sharing patient data. We implemented and evaluated numerous machine-learning models to forecast patient treatment needs, including Logistic Regression, Decision-Tree-Classifiers, Support-Vectors-Classifiers, Random-Forests, and Stacking-Classifiers. The Random Forest classifier achieved the best performance with an accuracy of 90 % and an F1 score of 80 %, demonstrating that it handled complex and imbalanced datasets. This FL-based approach not only complies with privacy regulations such as HIPAA and GDPR but also overcomes significant challenges in data sharing, making it ideal for rare disease research. By enabling secure data aggregation across institutions, the framework significantly enhances the ability to study rare diseases and accelerates the discovery of new treatments. Future directions include extending this framework to other areas of healthcare and incorporating advanced machine-learning techniques to enhance its capabilities further. This research sets the new standard for secure and collaborative healthcare data analysis and promotes innovation and ethical practices in rare disease research.</div></div>","PeriodicalId":100776,"journal":{"name":"Journal of Economy and Technology","volume":"3 ","pages":"Pages 177-189"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Economy and Technology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949948824000544","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This research announces that the fresh federated learning structure is designed to enhance the privacy-preserving analysis of electronic health records (EHRs), and multiple institutions in this framework permit secure collaboration among institutions, allowing them to train machine-learning replicas without directly sharing patient data. We implemented and evaluated numerous machine-learning models to forecast patient treatment needs, including Logistic Regression, Decision-Tree-Classifiers, Support-Vectors-Classifiers, Random-Forests, and Stacking-Classifiers. The Random Forest classifier achieved the best performance with an accuracy of 90 % and an F1 score of 80 %, demonstrating that it handled complex and imbalanced datasets. This FL-based approach not only complies with privacy regulations such as HIPAA and GDPR but also overcomes significant challenges in data sharing, making it ideal for rare disease research. By enabling secure data aggregation across institutions, the framework significantly enhances the ability to study rare diseases and accelerates the discovery of new treatments. Future directions include extending this framework to other areas of healthcare and incorporating advanced machine-learning techniques to enhance its capabilities further. This research sets the new standard for secure and collaborative healthcare data analysis and promotes innovation and ethical practices in rare disease research.